ENSC Enrolls Patient
Ensysce Biosciences enrolls first patient in final phase of PF614-MPAR-102 clinical study
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Ensysce Biosciences enrolls first patient in final phase of PF614-MPAR-102 clinical study
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.